BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2449319)

  • 1. Protease inhibitor and defective proteolysis in cystic fibrosis.
    Hsieh MC; Berry HK
    Dig Dis Sci; 1988 Mar; 33(3):282-8. PubMed ID: 2449319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
    Carrère J; Chazalette JP; Figarella C
    Biochim Biophys Acta; 1989 Dec; 993(2-3):137-42. PubMed ID: 2480820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination and characterization of immunoreactive trypsin in amniotic fluid from normal and cystic fibrosis fetuses.
    Borgström A; Sveger T; Kullander S; Svanberg L; Hösli P
    Pediatr Res; 1984 Oct; 18(10):957-9. PubMed ID: 6333665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of proteinase--inhibitor binding on accessibility of exposed tyrosines. A photochemically induced dynamic nuclear polarization study of bovine pancreatic trypsin inhibitor complexes with trypsin, chymotrypsin, and their zymogens.
    Muszkat KA; Weinstein S; Khait I; Vered M
    Biochemistry; 1982 Aug; 21(16):3775-9. PubMed ID: 7138805
    [No Abstract]   [Full Text] [Related]  

  • 5. Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation.
    Toldi V; Szabó A; Sahin-Tóth M
    J Biol Chem; 2020 Mar; 295(11):3447-3455. PubMed ID: 32014997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cystic fibrosis in the newborn by meconium analysis.
    Ryley HC; Neale LM; Brogan TD; Bray PT
    Arch Dis Child; 1979 Feb; 54(2):92-7. PubMed ID: 312055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition].
    Popov EM; Godzhaev NM; Aliev RE
    Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
    Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
    J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the inactivation of human and bovine trypsins and chymotrypsins by alpha1-proteinase inhibitor and of their reactivation by alpha2-macroglobulin.
    Aubry M; Bieth J
    Clin Chim Acta; 1977 Aug; 78(3):371-80. PubMed ID: 69511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The two alpha 2-macroglobulin-bound trypsin molecules have different affinities for the basic pancreatic trypsin inhibitor.
    Tourbez M; Dimicoli JL; Pochon F; Bieth JG
    Biochim Biophys Acta; 1984 Aug; 789(1):74-9. PubMed ID: 6205695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactive trypsin, chymotrypsin, and pancreatic secretory trypsin inhibitor in cord blood from infants with cystic fibrosis.
    Borgström A; Sveger T; Lindberg T; Kullander S; Svanberg L
    Acta Paediatr Scand; 1981 Sep; 70(5):619-21. PubMed ID: 7324908
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoreactive trypsin levels in neonates with meconium ileus.
    Steven LC; Gavel G; Young D; Carachi R
    Pediatr Surg Int; 2006 Mar; 22(3):236-9. PubMed ID: 16395608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between serine (pro)enzymes, and Kazal and Kunitz inhibitors.
    Antonini E; Ascenzi P; Bolognesi M; Gatti G; Guarneri M; Menegatti E
    J Mol Biol; 1983 Apr; 165(3):543-58. PubMed ID: 6188849
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of pH on the formation and dissociation of the complex of trypsin and PSTI].
    Seshimo T; Nohara T; Shikimi T; Nakase A
    Nihon Shokakibyo Gakkai Zasshi; 1992 May; 89(5):1279-85. PubMed ID: 1377760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cystic fibrosis by analysis of meconium for albumin and protease inhibitors.
    Ryley HC; Neale LM; Brogan TD; Bray PT
    Clin Chim Acta; 1975 Oct; 64(2):117-25. PubMed ID: 1081019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis alpha 2-macroglobulin protease interaction in vitro.
    Parsons M; Romeo G
    Clin Chim Acta; 1980 Jan; 100(3):215-24. PubMed ID: 6153299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.
    Ryley HC; Robinson PG; Yamashiro Y; Bradley DM
    J Clin Pathol; 1981 Aug; 34(8):906-10. PubMed ID: 7276210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pancreozymin and secretin on intraluminal enterokinase, trypsin, and chymotrypsin activities of cystic fibrosis and control children.
    Lebenthal E; Lee PC
    Digestion; 1982; 23(1):39-47. PubMed ID: 7044859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a screening system for cystic fibrosis: meconium or blood spot trypsin assay or both?
    Pederzini F; Faraguna D; Giglio L; Pedrotti D; Perobelli L; Mastella G
    Acta Paediatr Scand; 1990 Oct; 79(10):935-42. PubMed ID: 2124772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of newborn infants in cystic fibrosis. Evaluation of a 4-year study in Switzerland].
    Kraemer R; Meier HP; Hammerschlag P; Kaiser D; Sidiropoulos D
    Schweiz Med Wochenschr; 1977 Aug; 107(31):1105-9. PubMed ID: 302984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.